BEUDAMED
    1,530 results · 21ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 3 ×

    Columns, Immunoadsorption In Extracorporeal Systems

    FDA classification
    FDA Class 3 ·Columns, Immunoadsorption In Extracorporeal Systems

    Implant, Dermal, For Aesthetic Use In The Hands

    FDA classification
    FDA Class 3 ·Implant, Dermal, For Aesthetic Use In The Hands

    Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)

    FDA classification
    FDA Class 3 ·Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)

    Calibrator For Alpha-Fetoprotein In Mid-Pregnancy Maternal Serum

    FDA classification
    FDA Class 3 ·Calibrator For Alpha-Fetoprotein In Mid-Pregnancy Maternal Serum

    Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement

    FDA classification
    FDA Class 3 ·Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement

    Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations

    FDA classification
    FDA Class 3 ·Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations

    Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion

    FDA classification
    FDA Class 3 ·Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA classification
    FDA Class 3 ·Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    Fluorescence In Situ Hybridization, Platelet-Derived Growth Factor Receptor, Beta Polypeptide (Pdgfrb), Rearrangement

    FDA classification
    FDA Class 3 ·Fluorescence In Situ Hybridization, Platelet-Derived Growth Factor Receptor, Beta Polypeptide (Pdgfrb), Rearrangement

    Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence

    FDA classification
    FDA Class 3 ·Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence